Oct. 13—(StatePoint) Foot ulcers develop in about 15% of the 25 million Americans living with diabetes and are a top cause of hospitalization. These ulcers can lead to serious complications, such as ...

Foot infections and other complications can be side effects of diabetes, particularly among those whose disease is poorly controlled or uncontrolled. These patients often develop neuropathy or nerve ...

You probably check your feet for cuts, blisters, or fungal infections, but there’s an unusual warning sign hiding in your feet that could indicate developing diabetes long before your blood sugar ...

As a primary care provider, you can help patients set short-term goals to help their day-to-day lives. To begin, use ...

Foot health represents one of the most critical yet frequently overlooked aspects of diabetes management. The combination of vascular changes and nerve damage that often accompanies type 2 diabetes ...

Imagine you are walking barefoot on a beach with the warm sand, sun and sea breeze feeling good. Now imagine forgetting the sunscreen and by evening your skin is blistered, painful and peeling. That ...

Please provide your email address to receive an email when new articles are posted on . “The COVID-19 pandemic was an unprecedented time in history for the entire global community,” Laura Shin, DPM, ...

Living in the mountains has its perks, but also its challenges. If you have diabetes, one challenge you can’t afford to overlook is taking care of your feet. For most people, a blister or cut is no ...

Researchers from Singapore have recently introduced a mobile application that teaches diabetes patients about diabetic foot ulcers and self foot care. Developed in consultation with clinicians from ...

Guest: Michelle Diss (Nurse Practitioner). HealthLine is a fast paced show that keeps you informed of the latest developments in the worlds of medicine, health and wellness. Since January of 1996, ...

FibroBiologics Inc. FBLG on Monday released the first batch of its CYWC628 drug product to support its Phase 1/2 clinical ...